Androgen receptor splice variants and prostate cancer: From bench to bedside

Therapeutic interventions for advanced prostate cancer (PCa) center on inhibiting androgen receptor (AR) and downstream signaling pathways. Resistance to androgen deprivation therapy and/or AR antagonists is inevitable and molecular mechanisms driving castration-resistant PCa (CR-PCa) primarily invo...

Descripción completa

Detalles Bibliográficos
Autores principales: Wadosky, Kristine M., Koochekpour, Shahriar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392349/
https://www.ncbi.nlm.nih.gov/pubmed/28077788
http://dx.doi.org/10.18632/oncotarget.14537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392349/
https://www.ncbi.nlm.nih.gov/pubmed/28077788
http://dx.doi.org/10.18632/oncotarget.14537

Ejemplares similares